BEAMSTART Logo

Hanmi Pharmaceutical: Proxy Advisor KCG Supports Return of Founder's Sons to Board

Korea Economic Daily LogoKorea Economic Daily1 mo ago

 Hanmi Pharmaceutical: Proxy Advisor KCG Supports Return of Founder's Sons to Board - Korea Economic Daily

Quick Summary:

South Korea’s top proxy advisory firm has recommended that shareholders of Hanmi Science Co.vote in favor of the two sons of Hanmi Pharmaceutical Group’s late founder, who aim to return as board members of the group’s holding firm to prevent its merger with chemical giant OCI Holdings Inc., according to industry insiders on Tuesday.

On the other hand, the advisory firm has recommended shareholders not exercise their voting rights on the other four director candidates proposed by Hanmi Science.

The US advisor recommended that Hanmi Science shareholders vote for all the six board director candidates proposed by Hanmi Science’s board.


More Pictures

 Hanmi Pharmaceutical: Proxy Advisor KCG Supports Return of Founder's Sons to Board - Korea Economic Daily (Picture 1)

or

Article Details

Category: Economy

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-03-20 @ 18:04:17 (1 months ago)

News Timezone: GMT +8:00

News Source URL: kedglobal.com

Language: English

Article Length: 489 words

Reading Time: 3 minutes read

Sentences: 27 lines

Sentence Length: 19 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Korea Economic Daily

News ID: 20478598

View Article Analysis

About Korea Economic Daily

Korea Economic Daily Logo

Main Topics: Economy

Official Website: kedglobal.com

Update Frequency: 2 posts per day

Year Established: 1964

Headquarters: South Korea

News Last Updated: 22 hours ago

Coverage Areas: South Korea

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #91

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story " Hanmi Pharmaceutical: Proxy Advisor KCG Supports Return of Founder's Sons to Board" has 489 words across 27 sentences, which will take approximately 3 - 5 minutes for the average person to read.

Which news outlet covered this story?

The story " Hanmi Pharmaceutical: Proxy Advisor KCG Supports Return of Founder's Sons to Board" was covered 1 months ago by Korea Economic Daily, a news publisher based in South Korea.

How trustworthy is 'Korea Economic Daily' news outlet?

Korea Economic Daily is a fully independent (privately-owned) news outlet established in 1964 that covers mostly economy news.

The outlet is headquartered in South Korea and publishes an average of 2 news stories per day.

It's most recent story was published 22 hours ago.

What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #20478598
  • URL: https://beamstart.com/news/proxy-advisor-kcgs-backs-hanmi-17109263724570

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $100,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2024 BEAMSTART. All Rights Reserved.